Chelating N-heterocyclic carbene-carboranes offer flexible ligand coordination to IrIII, RhIII and RuII: effect of ligand cyclometallation in catalytic transfer hydrogenation by Holmes, J et al.
This is an author produced version of Chelating N-heterocyclic carbene-carboranes offer 
flexible ligand coordination to IrIII, RhIII and RuII: effect of ligand cyclometallation in 
catalytic transfer hydrogenation.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/103401/
Article:
Holmes, J, Pask, CM and Willans, CE orcid.org/0000-0003-0412-8821 (2016) Chelating 
N-heterocyclic carbene-carboranes offer flexible ligand coordination to IrIII, RhIII and RuII: 
effect of ligand cyclometallation in catalytic transfer hydrogenation. Dalton Transactions, 
45 (40). pp. 15818-15827. ISSN 1477-9226 
https://doi.org/10.1039/C6DT02079H
© 2016, The Royal Society of Chemistry. This is an author produced version of a paper 
published in Dalton Transactions. Uploaded in accordance with the publisher' 
self-archiving policy.
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
Journal Name  
ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1  
Please do not adjust margins 
Please do not adjust margins 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Chelating N-heterocyclic carbene-carboranes offer flexible ligand 
coordination to IrIII, RhIII and RuII: effect of ligand cyclometallation 
in catalytic transfer hydrogenation  
Jordan Holmes,a Christopher M. Paska and Charlotte E. Willans*c 
Imidazolium salts linked by an ethyl tether to closo-dicarbadodecaboranes were reacted with [IrCp*Cl2]2, [RhCp*Cl2]2 or 
[Ru(p-cymene)Cl2]2 in the presence of Ag2O to prepare complexes of the type [MCp*(NHC)Cl2] (M = Ir, Rh; NHC = N-
heterocyclic carbene) or [Ru(p-cymene)(NHC)Cl2]. When the NHC contained an N-tBu substituent, C-H activation of the tBu 
and subsequent alkyl coordination was observed at Ir. Coordination of the closo-dicarbadodecaborane moiety to Ir was 
possible to give 7-membered metallacycles, coordinated through the carbenic carbon of the NHC and either a carbon atom 
or a boron atom of the carborane. Examination of the Ir complexes in the transfer hydrogenation of acetophenone to 1-
phenylethanol reveals that cyclometallation of the carborane moiety is important for catalytic efficacy, indicating a 
bifunctional mechanism and involvement of the dicarbadodecaborane anion.
Introduction 
N-Heterocyclic carbenes (NHCs) represent an attractive 
alternative to phosphines as ligands in many organometallic-
catalysed reactions, and are showing promise in the biomedical 
field.1-6 Advantages of NHCs over common ligand types include 
the strong metal-carbene bond which is able to stabilise an 
array of metals in various oxidation states, and the ability to 
fine-tune the steric and electronic effects of the ligand through 
modification of nitrogen substituents and backbone 
substituents respectively. Nitrogen substituents on NHCs are 
usually alkyl or aryl groups, with neutral (e.g. pyridyl, 
oxazoline)7-15 or anionic (e.g. alkoxide, amide)16-20 donor 
functionalities often being incorporated into the substituents. 
These tethering groups enable ligands to chelate a metal centre, 
allowing fine control over stability, steric and electronic 
properties. The N-substituents may further become involved in 
catalysis in a bifunctional manner, for example in academically 
and industrially viable hydrogenation and transfer 
hydrogenation reactions.21-24 
Lavallo and co-workers have previously reported NHC 
ligands bearing a closo-carbadodecaborate substituent.25, 26 
Coordination of the ligands to Au through the NHC yields 
zwitterionic and anionic complexes.27 We have recently 
introduced a new class of NHC ligands which contain either a 
closo-dicarbadodecaborane (neutral and anionic) or a nido-
dicarbaundecaborane dianion.28 Versatile coordination to RhI 
through both the NHC and either a closo-dicarbadodecaborane 
anion, or a nido-dicarbaundecaborane dianion was 
demonstrated. The nido-carborane ligands furnish homo-
bimetallic complexes, whereas the closo-carborane ligand 
chelates the RhI centre, coordinating through both the NHC and 
a carbon atom of the carborane. Herein, we report a valuable 
addition to the NHC-carborane ligand class, and their reactivity 
with IrIII, RhIII and RuII. Examination of the IrIII complexes in the 
transfer hydrogenation of acetophenone to 1-phenylethanol 
demonstrates that the complexes are catalytically viable, with a 
profound ligand effect observed upon cyclometallation.  
Results and discussion 
Ligand precursors 1a-1c were identified for this study and were 
prepared using a convenient nucleophilic substitution 
reaction.28 Reaction of 1-bromoethyl-1,2-dicarba-closo-
dodecaborane with a stoichiometric amount of N-tbutyl or N-
methyl imidazole in a minimal amount of anhydrous toluene at 
100 °C gave the corresponding imidazolium bromide salts 1a 
and 1b respectively (Scheme 1). (1-Bromoethyl)(2-methyl)-1,2-
dicarba-closo-dodecaborane was prepared from 1-methyl-1,2-
dicarba-closo-dodecaborane (see experimental) and reacted 
with N-methyl imidazole to give imidazolium bromide 1c.  The 
novel salts 1b and 1c were fully characterised using 
multinuclear NMR spectroscopy, mass spectrometry, elemental 
analysis and X-ray crystallography. The solid-state structures of 
1b and 1c show an ethyl tether linking a nitrogen atom of the 
imidazolium with a carbon atom of each carborane (Figure 1). 
The carboranyl carbon atoms were identified using the VCD 
method,29 with the carboranyl C-H proton in 1b resonating at 
5.37 ppm in the 1H NMR spectrum (500 MHz, dmso-d6). 
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Scheme 1  Synthesis of imidazolium ligand precursors 1a-1c.  
 
Fig 1  Molecular structure of imidazolium bromide salts 1b (top) and 1c (bottom). H 
atoms are omitted for clarity and thermal ellipsoids are depicted at 50% probability. 
Reaction of compound 1a with [IrCp*Cl2]2 in the presence of 
Ag2O in CH2Cl2 gave an IrIII-NHC complex 3a (Scheme 2). In 
addition to NHC formation, the 1H NMR spectrum revealed that 
C-H activation of a methyl of the tBu group had occurred, with 
concomitant coordination to the metal. The non-equivalent 
diastereotopic protons of the metallated CH2 group appear at 
3.06 and 2.39 ppm in the 1H NMR spectrum (300 MHz, CD2Cl2), 
with a coupling of 12.0 Hz. The non-cyclometallated complex 2a 
was not observed in this reaction, indicating that aliphatic C-H 
activation is facile, as previously seen in related IrIII-NHCs.30  
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Scheme 2  Reaction of imidazolium 1a with an IrIII precursor and Ag2O to yield 
cyclometallated complexes 3a and 4a. 
Our previous work has shown that solvent-assisted C-H 
activation/deprotonation of the carborane moiety occurs in 
MeCN,28 hence the reaction with 1a was carried out in MeCN 
with excess Ag2O. In addition to Ir-NHC formation, 
cyclometallation through the carborane did occur to give 4a, 
though in this case the closo-dicarbadodecaborane anion 
coordinates to the metal through a boron atom, rather than a 
carbon atom as observed in RhI complexes.28 This was 
confirmed through the observation of a broad resonance at 
3.21 ppm, integrating to 1H in the 1H NMR spectrum (500 MHz, 
C6D6), indicative of the carboranyl C-H remaining protonated. 
The 1H NMR spectrum of 4a exhibits two sets of resonances in 
a 7:3 ratio due to diasteroisomers, as a result of the sterogenic 
metal centre and a mixture of B3 and B6 metallation.31, 32 
Crystals of complex 4a suitable for X-ray diffraction analysis 
were obtained from slow evaporation of a MeCN solution, and 
provide unambiguous confirmation that intramolecular C-H 
activation of the tBu group had occurred to give a five-
membered metallacycle, with a C-Ir-C bite angle of 76.27(12) ° 
(Figure 2). In addition, coordination through a boron atom of 
the closo-carborane results in a seven-membered metallacycle, 
with a C-Ir-B bite angle of 85.65(14) °, forming an interesting 
and structurally distinct (7,5)-bicyclo-metallated system. The 
molecular structure of 4a can be regarded as a distorted piano 
stool geometry, with an Ir-Ccarbene bond length of 1.956(3) Å, 
which is comparatively short for IrCp*(NHC)-type complexes.33-
37 The Ir-CH2 distance of 2.128(3) Å is moderately long 
compared to other IrIII-alkyl-cyclometallated complexes.30, 33, 38 
The carboranyl carbon atoms were determined using the VCD 
method, and revealed a particularly elongated B3 vertex to 
centroid distance of 1.89 Å, which are typically in the range 
1.72-1.78 Å.31, 39 It can be proposed that the metallated 
carborane B vertex elongates to relieve steric encumbrance 
close to the metal centre. 
 
Fig 2  Molecular structure of IrIII-NHC complex 4a. H atoms are omitted for clarity and 
thermal ellipsoids are depicted at 50% probability. 
Complexes 3a and 4a were isolated in relatively low (but 
useable) yields, with attempts to improve them unsuccessful. 
Therefore, to increase yield and enable isolation of a non-
cyclometallated IrIIICp*(NHC)Cl2-type complex of an NHC-
carborane ligand, the sterics were reduced by replacing the tBu 
substituent of the NHC with a methyl group (1b). Ligand 
precursor 1b was reacted with [IrCp*Cl2]2 under the same 
conditions as previously to give the desired IrIIICp*(NHC)Cl2 
complex 2b in excellent yield (Scheme 3). The corresponding 
RhCp*(NHC)Cl2 (5b) and Ru(p-cymene)(NHC)Cl2 (6b) complexes 
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were also synthesised in good yield using analogous 
procedures. Complexes 2b, 5b and 6b were fully characterised 
by multinuclear NMR spectroscopy, mass spectrometry and 
elemental analysis. As expected, upon deprotonation and 
subsequent coordination of the NHC group, the imidazolium C2-
proton resonance is absent from the 1H NMR spectra in each 
case. The CH2 protons of the ethyl linkers are diastereotopic, 
indicating hindered rotation about the M-Ccarbene bonds at room 
temperature. Furthermore, there appears to be a second minor 
product in the 1H NMR spectrum, with two resonances that 
appear close together for both the N-Me and Cp* groups. This 
may be due to the complexes being in equilibrium with 
cyclometallated derivatives in solution,40 though mass 
spectrometry and elemental analysis data are indicative of only 
the non-cyclometallated products. The carboranyl C-H 
resonances appear at 4.45 ppm (2b), 4.62 ppm (5b) (300MHz, 
CDCl3) and 4.54 ppm (6b) (500MHz, CD2Cl2), and the 11B{1H} 
NMR spectra display characteristic resonances for closo-
carboranes, with peaks ranging from -2 to -13 ppm. 
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Scheme 3  Reaction of imidazolium 1b with IrIII, RhIII and RuII precursors to give complexes 
2b, 5b and 6b. 
Crystals of 2b and 6b suitable for X-ray diffraction analysis were 
obtained from CH2Cl2/hexane and slow evaporation of a 
concentrated MeCN solution respectively. The solid-state 
structures (Figure 3) show piano stool geometry around the 
metal centres, with each metal bearing two chloride atoms, an 
NHC and either Cp* (2b) or p-cymene (6b). The M-Ccarbene bond 
lengths of 1.92(3) Å (2b) and 2.064(7) Å (6b) are relatively short 
when compared to other IrCp*(NHC)Cl2 and Ru(p-
cymene)(NHC)Cl2 complexes in the literature,37, 41-45 which may 
be an effect of the carborane substituent causing the carbenic 
carbon to be more nucleophilic than other NHCs. 
 
 
Fig. 3  Molecular structure of complexes 2b (top) and 6b (bottom). H atoms are omitted 
for clarity and thermal ellipsoids are depicted at 30% (2b) and 50% (6b) probability. 
Similarly to complex 3a, the Ir complex 2b underwent 
cyclometallation upon reaction with Ag2O in MeCN. Following 
cyclometallation, the NMR data revealed two overlapping sets 
of resonances, which were assigned as a mixture of Ccarborane- 
and Bcarborane-cyclometallated complexes 7b and 8b (Scheme 4). 
The carboranyl C-H appears as two resonances in the 1H NMR 
spectrum, attributable to a diasterotopic mixture of B3 and B6 
metallation. Mass spectrometry data revealed just one signal at 
579.3350, attributable to [7b/8b-Cl]+, with elemental analysis 
providing evidence for the presence of only 7b and/or 8b. It is 
intriguing that the N- tBu substituted ligand leads selectively to 
only B-cyclometallation (4a), whereas a mixture of B- and C-
cyclometallation is observed with the N-Me substituted ligand. 
Such selectivity in 4a is likely due to elongation of the B vertex 
allowing reduction of steric encumbrance around the metal, 
which is not necessary in the case of the N-Me substituted 
ligand. Surprisingly, Rh and Ru complexes 5b and 6b do not 
cyclometallate under the same reaction conditions, which may 
indicate that an M-C/B interaction occurs prior to 
deprotonation, with the higher charge density of IrIII compared 
to RhIII and RuII rendering the C-H/B-H proton more acidic. 
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Scheme 4  Synthesis of mixed metallacycles 7b and 8b. 
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To negate the formation of a mixture of cyclometallated 
products, an alternative route was developed to furnish 
complex 7b (Scheme 5). Ligand precursor 1b was reacted with 
nBuLi to deprotonate both the imidazolium NCHN proton and 
the carboranyl CH proton, followed by reaction with [IrCp*Cl2]2. 
Analysis of the resulting product revealed NHC coordination and 
Ir-Ccarborane cyclometallation, however, halide exchange had also 
occurred to give a mixture of Ir-Cl and Ir-Br (originating from 
LiBr). X-ray crystallography analysis showed 70% bromide and 
30% chloride occupancy in the solid-state (Figure 4). To remove 
bromide ions from the reaction, attempts were made to 
synthesise the imidazolium chloride ligand precursor from 1-
chloroethyl-1,2-dicarba-closo-dodecaborane, though the 
nucleophilic substitution reaction was sluggish, furnishing 7% 
product which was contaminated with nido-carborane species. 
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Scheme 5  Synthesis of Ir-NHC-Ccarborane metallacycle 7b (top), and Ir-NHC-Bcarborane 
metallacycle 8c via non-cyclometallated complex 2c (bottom). 
 
Fig. 4  Molecular structure of complex 7b. H atoms are omitted for clarity and thermal 
ellipsoids are depicted at 50% probability. The halide labelled Br(1) was found to be a 
mixture of Br (70%) and Cl (30%). 
To prepare a cyclometallated complex that coordinates through 
a carboranyl boron atom, C-Me protected ligand precursor 1c 
was reacted with [IrCp*Cl2]2 in the presence of Ag2O. As 
previously observed, reaction in CD2Cl2 furnishes the non-
cyclometallated product 2c. X-ray diffraction analysis of 
complex 2c showed the expected IrCp*(NHC)Cl2 species, with 
an Ir-Ccarbene bond length of 2.002(18) Å (Figure 5). As observed 
in 2b, complex 3c undergoes cyclometallation upon reaction 
with Ag2O in MeCN to give 8c in 44% yield. 
 
Fig. 5  Molecular structure of complex 2c. H atoms are omitted for clarity and thermal 
ellipsoids are depicted at 50% probability. 
Catalytic viability in transfer hydrogenation 
The reduction of ketones via transfer hydrogenation provides a 
mild route to secondary alcohols without the need for 
pressurised H2 gas.46 Several different metals have been shown 
to catalyse the transfer hydrogenation reaction, including Ir, Rh 
and Ru, many of which contain NHC ligands.21-23, 36 To assess the 
catalytic feasibility of our novel IrIII complexes bearing NHC-
carborane ligands, complexes 2b, 7b/8b mixture, 7b and 8c 
were examined in the transfer hydrogenation of acetophenone, 
alongside [IrCp*Cl2]2 as a benchmark reaction (Table 1). 
Furthermore, as a dicarbadodecaborane is thought to mimic the 
sterics created by rotation of a planar phenyl group through 
360°, the phenyl derivative 2d was prepared and examined for 
useful comparison, in addition to the cyclometallated phenyl 
complex 7e (Scheme 6).  
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Scheme 6  Synthesis of phenyl-derivatives 2d and 7e. 
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Fig. 6  Molecular structure of complex 2d. H atoms are omitted for clarity and thermal 
ellipsoids are depicted at 50% probability. 
Table 1  Examination of a range of IrIII catalysts in the transfer hydrogenation of 
acetophenone to 1-phenylethanol. 
Ph
O OH
Ph
OH O
Catalyst, tBuOK
82 °C, 1 hour
+ +
 
 Catalyst Catalyst Loading 
(mol%) 
Conversion 
(%)# 
1 No catalyst 0 8 
2 [IrCp*Cl2]2 1ƨ 68 
3 2b 1 33 
4 2d 1 25 
5 7b/8b 1 >99 
6 7b/8b 0.5 91 
7 7b 1 75 
8 8c 1 >99 
9 8c 0.5 82 
1
0 
7e 1 39 
1
1 
7b/8bÁ 1 0 
Conditions: Acetophenone (1 mmol), 2-propanol (2.3 mL, 30 mmol), tBuOK (0.1 
mmol, Áno base added), catalyst (ƨ1.0 mol% per Ir), internal standard = 1,3,5-
trimethoxybenzene (0.33 mmol), 82 °C, 1 hour. #Conversion was calculated by 1H 
NMR spectroscopy, by measuring the integration of the methyl resonance of 1-
phenylethanol and comparing to the TMB internal standard. Conversion values are 
an average of two separate runs. 
The transfer hydrogenation reaction with [IrCp*Cl2]2 as the 
catalyst gave a reasonable conversion of 68% after 1 hour (entry 
2). Incorporating an NHC ligand with a dicarbadodecaborane 
substituent (2b) into the complex had a significant deactivating 
effect, with a conversion of 33% after 1 hour (entry 3), which 
decreased further to 25% when exchanging the 
dicarbadodecaborane group for phenyl (2d) (entry 4). However, 
cyclometallation of the carborane moiety enhances catalysis 
greatly compared to the non-cyclometallated counterparts 
(entries 5-9). The C/B-cyclometallated mixture 7b/8b catalyses 
the hydrogenation of acetophenone to 1-phenylethanol 
quantitatively after 1 hour (entry 5), with a 91% conversion 
when the catalyst loading is lowered to 0.5 mol% (entry 6). 
When using 1.0 mol% of the C-cyclometallated complex 7b, a 
conversion of 75% was achieved after 1 hour (entry 7), which 
indicates that the B-cyclometallated complex is more active 
than the C-cyclometallated. Indeed, when B-cyclometallated 
complex 8c was tested, quantitative conversion was observed 
with 1.0 mol% after 1 hour (entry 8). However, 0.5 mol% 8c 
yielded 82% conversion (entry 9), which is lower than the C/B-
cyclometallated mixture 7b/8b. This indicates that either the Ir-
halide has an effect on catalysis, with Cl being more activating 
than Br, or that the mixed C/B-cyclometallated complexes work 
synergistically. Cyclometallation of a phenyl group has little 
effect upon the outcome of the reaction, with a conversion of 
only 39% when using complex 7e (entry 10). The significant 
enhancement in activity upon cyclometallation of a carborane 
substituent, which is not observed upon cyclometallation of a 
phenyl substituent, is likely a result of metal-ligand bifunctional 
catalysis, in which the carborane anion becomes involved.  
Conducting the transfer hydrogenation reaction in the absence 
of tBuOK shuts down catalysis (entry 11), which may suggest 
that the active catalyst is an alkoxide rather than a chloride 
species. Based upon these findings, a proposed mechanism for 
the transfer hydrogenation reaction is given in Scheme 7, which 
may proceed via an inner-sphere22 or an outer-sphere47 
mechanism. 
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Scheme 7  Proposed inner-sphere or outer-sphere mechanism for the transfer 
hydrogenation of acetophenone catalysed by an IrIII complex bearing a cyclometallated 
NHC-dicarbadodecaborane ligand. 
Conclusion 
In summary, we have reported a series of complexes bearing 
NHC-carborane ligands. Variable coordination has been 
observed through the NHC and through either a carbon atom or 
a boron atom of the carborane, which highlights their potential 
as a flexible and distinct ligand class. Through judicious choice 
of reaction conditions and ligand precursor, selective C- or B-
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cyclometallation can be effected. The cyclometallated 
complexes are validated active catalysts in the transfer 
hydrogenation of acetophenone, with a bifunctional 
mechanism proposed in which the dicarbadodecaborane 
moiety is involved. 
Experimental 
General 
All manipulations were carried out under an inert atmosphere 
by means of standard Schlenk line or Glovebox techniques. 
Anhydrous solvents were prepared by passing over activated 
alumina to remove water, copper catalyst to remove oxygen 
and molecular sieves to remove any remaining water, via the 
Dow-Grubbs solvent system, and then freeze-pump-thaw 
degassed prior to use. 1-tButylimidazole,48 6,9-
bis(acetonitrile)decaborane,49 1-bromoethyl-1,2-dicarba-closo-
dodecaborane,50 1-methyl-1,2-dicarba-closo-dodecaborane,50 
[Ir(Cp*)Cl2]2,51 [Rh(Cp*)Cl2]2,51 [Ru(p-cymene)Cl2]2,52 1d,53 1e41 
and 7e41 were prepared using literature methods. All other 
reagents were purchased and used without further purification. 
NMR spectra were recorded on a Bruker AV500 or a Bruker 
DPX300 spectrometer. 1H NMR and 13C{1H} NMR chemical shifts 
were referenced against residual solvent peaks. The 11B{1H} 
NMR spectra were referenced externally to BF3.OEt2. 
Assignment of 1H and 13C{1H} NMR spectra for all complexes was 
aided by the use of 2D 1H1H COSY, 1H13C HMQC, 1H13C HMBC 
and 13C{1H} DEPT 135 experiments. Mass spectra were collected 
on a Bruker Daltonics (micro TOF) instrument operating in the 
electrospray mode. Elemental analyses were performed by Mr 
Stephen Boyer at London Metropolitan University. 
(1-Hydroxyethyl)(2-methyl)-1,2-dicarba-closo-dodecaborane 
1-Methyl-1,2-dicarba-closo-dodecaborane (300 mg, 1.90 mmol) 
was added to a Schlenk flask and degassed. Anhydrous THF (10 
mL) was added and cooled to -78°C. A 1.6 M solution of nBuLi in 
hexane (1.17 mL, 1.87 mmol) was added dropwise and stirred 
for 30 minutes at -78°C. The temperature was raised to 0°C and 
a 2.5 M solution of ethylene oxide in THF (1.13 mL, 2.81 mmol) 
was added dropwise and stirred at 0°C for 1 hour. The reaction 
was quenched by adding a saturated solution of NH4Cl (5 mL), 
and the aqueous phase was extracted with ethyl acetate (3 × 10 
mL). The organic fractions were combined and dried over 
MgSO4, filtered and solvent removed in vacuo. Hexane (3 mL) 
was added and cooled to -15°C for 3 hours. The resulting white 
crystals were filtered, washed with hexane at 0°C (5 mL) and 
dried in vacuo. Yield: 325 mg, 1.61 mmol (85 %). 1H NMR (500 
MHz, dmso-d6 ? ?ɷ4.87 (s, 1H, OH), 3.56 (t, J = 5 Hz, 2H, CH2OH), 
2.44 (t, J = 5 Hz, 2H, CH2), 2.09 (s, 3H, CH3). 13C{1H} NMR (126 
MHz, dmso-d6 ? ? ɷ77.2 (carboranyl quaternary C), 76.0 
(carboranyl quaternary C), 59.5 (CH2OH), 36.9 (CH2), 22.6 (CH3). 
11B{1H} NMR (161 MHz, dmso-d6 ? ?ɷ-4.9 (1B), -6.4 (1B), -8.9 (2B), 
-10.0 (2B), -10.9 (4B). Anal. Calcd for C5H18B10O: C, 29.69; H, 
8.97. Found: C, 29.77; H, 9.02. 
(1-Bromoethyl)(2-methyl)-1,2-dicarba-closo-dodecaborane 
To a Schlenk flask was added (1-hydroxyethyl)(2-methyl)-1,2-
dicarba-closo-dodecaborane (360 mg, 1.78 mmol) and 
anhydrous CH2Cl2 (5 mL). This was cooled to 0°C and PPh3 (543 
mg, 2.07 mmol) and N-bromosuccinimide (368 mg, 2.07 mmol) 
was added and stirred at 0°C for 3 hours. The organic phase was 
washed with H2O (4 × 10 mL), dried over MgSO4, filtered and the 
solvent removed in vacuo. Et2O (10 mL) was added and the 
suspension was filtered through a 5 cm silica plug which was 
flushed with Et2O (2 × 10 mL). The solvent was removed from 
the filtrate in vacuo to give the product as a white crystalline 
solid. Yield: 365 mg, 1.38 mmol (78 %). 1H NMR (500 MHz, 
dmso-d6 ? ?ɷ3.60 (t, J = 10 Hz, 2H, CH2Br), 2.86 (t, J = 10 Hz, 2H, 
CH2), 2.12 (s, 3H, CH3). 13C{1H} NMR (126 MHz, dmso-d6 ? ?ɷ76.9 
(carboranyl quaternary C), 76.2 (carboranyl quaternary C), 36.5 
(CH2Br), 28.9 (CH2), 22.4 (CH3). 11B{1H} NMR (161 MHz, dmso-
d6 ? ?ɷ-4.4 (1B), -6.3 (1B), -9.0 (2B), -9.9 (2B), -10.9 (4B). Anal. 
Calcd for C5H17B10Br: C, 22.65; H, 6.46. Found: C, 22.77; H, 6.48. 
Compound 1a 
1-Bromoethyl-1,2-dicarba-closo-dodecaborane (500 mg, 1.99 
mmol), 1-tbutylimidazole (246 mg, 1.98 mmol) and anhydrous 
toluene (3 mL) were added to an ampoule and heated at 100°C 
for 18 hours. The reaction was cooled to room temperature, 
filtered, and the solid washed with toluene (3 × 10 mL) to give 
an off white crystalline solid. This was recrystallised from MeOH 
(3 mL) / Et2O (30 mL), filtered and dried in vacuo to give 1a as a 
white crystalline solid. Yield: 529 mg, 1.41 mmol (71 %). 1H NMR 
(500 MHz, dmso-d6 ? ?ɷ ? ? ? ? ?Ɛ ? ?, ?imidazolium NCHN), 8.03 (t, 
J = 1.9 Hz, 1H, imidazolium NCH), 7.90 (t, J = 1.9 Hz, 1H, 
imidazolium NCH), 5.38 (br. s, 1H, carboranyl CH), 4.33 (m, 2H, 
CH2), 2.99 (m, 2H, CH2), 1.57 (s, 9H, (CH3)3). 13C{1H} NMR (126 
MHz, dmso-d6 ? ?ɷ134.9 (imidazolium NCN), 122.6 (imidazolium 
NCH), 120.2 (imidazolium NCH), 72.4 (carboranyl quaternary C), 
63.2 (carboranyl CH), 59.6 (C(CH3)3), 47.0 (CH2), 35.3 (CH2), 28.9 
((CH3)3). 11B{1H} NMR (161 MHz, dmso-d6 ? ?ɷ -2.8 (1B), -5.5 (1B), 
-9.6 (2B), -11.8 (6B). HRMS (ESI+): m/z 295.3188 [C11H27B10N2]+, 
Calcd for [M-Br]+ 295.3177. 
Compound 1b 
Compound 1b was prepared as described for 1a, from 1-
bromoethyl-1,2-dicarba-closo-dodecaborane (500 mg, 1.99 
mmol) and 1-methylimidazole (162 mg, 1.97 mmol). Following 
purification the product was isolated as a fluffy crystalline white 
solid. Yield: 490 mg, 1.47 mmol (75 %). 1H NMR (500 MHz, 
dmso-d6 ? ?ɷ ? ? ? ? ?Ɛ ? ?, ?ŝŵŝĚĂǌŽůŝƵŵEHN), 7.84 (t, J = 2.0 Hz, 
1H, imidazolium NCH), 7.71 (t, J = 2.0 Hz, 1H, imidazolium NCH), 
5.37 (br. s, 1H, carboranyl CH), 4.35 (m, 2H, CH2), 3.86 (s, 3H, 
CH3), 2.94 (m, 2H, CH2). 13C{1H} NMR (126 MHz, dmso-d6 ? ? ɷ
137.0 (imidazolium NCN), 123.6 (imidazolium NCH), 122.3 
(imidazolium NCH), 72.5 (carboranyl quaternary C), 63.1 
(carboranyl CH), 46.9 (CH2), 35.8 (CH3), 35.3 (CH2). 11B{1H} NMR 
(161 MHz, dmso-d6): -3.0 (1B), -5.6 (1B), -9.7 (2B), -11.8 (4B), -
12.9 (2B). HRMS (ESI+): m/z [C8H21B10N2]+ 253.2714, Calcd for 
[M-Br]+ 253.2706. Anal. Calcd for C8H21B10N2Br: C, 28.83; H, 
6.35; N, 8.41. Found: C, 28.72; H, 6.41; N, 8.27. Crystals suitable 
for X-ray diffraction analysis were grown via slow diffusion of 
Et2O into a concentrated solution of 1b in MeCN. 
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Compound 1c 
Compound 1c was prepared as described for 1a, from (1-
bromoethyl)(2-methyl)-1,2-dicarba-closo-dodecaborane (100 
mg, 0.38 mmol) and 1-methylimidazole (31 mg, 0.38 mmol) in 
anhydrous toluene (1 mL), with a reaction time of 6 hours. After 
purification the product was obtained as a fluffy crystalline 
white solid. Yield: 79 mg, 0.23 mmol (61 %). 1H NMR (300 MHz, 
CD3K ? ? ɷ  ? ? ? ?  ?Ɛ ?  ?, ? ŝŵŝĚĂǌŽůŝƵŵ EHN), 7.75 (m, 1H, 
imidazolium NCH), 7.59 (m, 1H, imidazolium NCH), 4.46 (m, 2H, 
CH2), 3.93 (s, 3H, CH3), 2.95 (m, 2H, CH2), 2.15 (s, 3H, carboranyl 
CH3). 13C{1H} NMR (75 MHz, CD3K ? ?ɷ ? ? ? ? ?(imidazolium NCN), 
125.1 (imidazolium NCH), 123.8 (imidazolium NCH), 77.5 
(carboranyl quaternary C), 75.6 (carboranyl quaternary C), 48.9 
(CH2), 36.6 (CH2), 35.2 (CH3), 23.6 (carboranyl-CH3). 11B{1H} NMR 
(96 MHz, CD3OD): -3.9 (1B), -5.9 (1B), -9.6 (4B), -10.5 (4B). HRMS 
(ESI+): m/z [C9H23B10N2]+ 267.2875, Calcd for [M-Br]+ 267.2863. 
Anal. Calcd for C9H23B10N2Br: C, 31.13; H, 6.68; N, 8.07. Found: 
C, 31.02; H, 6.79; N, 8.12. Crystals suitable for X-ray diffraction 
analysis were grown via slow diffusion of Et2O into a 
concentrated solution of 1c in MeCN. 
Ir complex 3a 
To a Schlenk flask was added 1a (100 mg, 0.27 mmol), Ag2O (34 
mg, 0.15 mmol), [Ir(Cp*)Cl2]2 (120 mg, 0.15 mmol) and 
anhydrous CH2Cl2 (5 mL) along with some 4Å molecular sieves. 
The reaction was heated at 40°C for 16 hours, filtered through 
a 2 cm silica plug and flushed with CH2Cl2 (3 × 10 mL). The 
solvent was removed from the filtrate in vacuo and the solid 
added to Et2O (10 mL). This was filtered and removal of the 
solvent from the filtrate in vacuo gave 3a as an orange powder. 
Yield: 63 mg, 0.10 mmol (37 %). 1H NMR (300 MHz, CD2Cl2 ? ?ɷ 
6.87 (d, J = 3.0 Hz, 1H, NCH), 6.80 (d, J = 3.0 Hz, 1H, NCH), 4.56 
(td, J = 12.0 Hz, 6.0 Hz, 1H, CH2), 4.13 (br. s, 1H, carboranyl CH), 
3.95 (m, 1H, CH2), 3.06 (d, J = 12.0 Hz, 1H, CH2-Ir), 2.98 (m, 1H, 
CH2), 2.63 (m, 1H, CH2), 2.39 (d, J = 12.0 Hz, 1H, CH2-Ir), 
1.78/1.74 (Cp*), 1.53 (s, 3H, CH3), 1.15 (s, 3H, CH3). 13C{1H} NMR 
(75 MHz, CDCl3 ? ? ɷ164.0 (NCN), 119.7 (NCH), 117.3 (NCH), 
89.7/89.4 (quaternary Cp*), 73.0 (carboranyl quaternary C), 
65.9 (CH3), 62.7 (carboranyl CH), 49.3 (CH2), 39.7 (CH2), 
31.4/31.0 (CH3), 28.3 (Ir-CH2), 10.1/10.0 (Cp*). 11B{1H} NMR (96 
MHz, CDCl3 ? ? ɷ-2.3, -5.4, -9.5, -11.1, -12.6. HRMS (ESI+): m/z 
[C21H40B10N2Ir]+ 621.3803, Calcd for [M-Cl]+ 621.3811. Anal. 
Calcd for C22H42B10ClN2Ir: C, 38.43; H, 6.14; N, 4.27. Found: C, 
38.50; H, 6.21; N, 4.35. 
Ir complex 4a 
To a Schlenk flask was added 1a (100 mg, 0.27 mmol), Ag2O (94 
mg, 0.41 mmol), [Ir(Cp*)Cl2]2 (108 mg, 0.14 mmol) and 
anhydrous MeCN (5 mL) along with some 4Å molecular sieves. 
The reaction was heated at 70°C for 24 hours, filtered through 
a 2 cm silica plug and flushed with MeCN (3 × 10 mL). The 
solvent volume was reduced to 5 mL in vacuo resulting in 4a as 
colourless crystals, which were filtered, washed with pentane (5 
mL) and dried in vacuo. Yield: 41 mg, 0.06 mmol (22 %). 1H NMR 
(500 MHz, C6D6): Major isomer (70 %) ɷ 6.11 (d, 1H, J = 2.0 Hz, 
NCH), 5.96 (d, J = 2.0 Hz, 1H, NCH), 4.06 (td, J = 13.1 Hz, 3.0 Hz, 
1H, CH2), 3.24 (d, J = 10.0 Hz, 1H, CH2-Ir), 3.21 (br. s, 1H, 
carboranyl CH), 2.64 (m, 2H, CH2), 2.63 (d, J = 10.0 Hz, 1H, CH2-
Ir), 1.87 (m, 1H, CH2), 1.61 (Cp*), 1.44 (s, 1H, CH3), 1.06 (s, 1H, 
CH3). Minor isomer (30 %) ɷ5.86 (d, 1H, J = 2.0 Hz, NCH), 5.74 
(d, 1H, J = 2.0 Hz, NCH), 4.35 (td, J = 13.8 Hz, 3.0 Hz, 1H, CH2), 
3.07 (d, J = 10.5 Hz, 1H, CH2-Ir), 3.21 (br. s, 1H, carboranyl CH), 
2.64 (m, 2H, CH2), 2.63 (d, J = 10.5 Hz, 1H, CH2-Ir), 2.18 (m, 1H, 
CH2), 1.98 (m, 1H, CH2), 1.73 (Cp*), 1.26 (s, 1H, CH3), 0.98 (s, 1H, 
CH3). 13C{1H} NMR (75 MHz, C6D6): ɷ 117.6/117.5 (NCH), 
116.7/116.6 (NCH), 93.5/93.0 (quaternary Cp*), 65.8/65.5 
(carboranyl quaternary C), 59.9/58.3 (carboranyl CH), 45.1/44.3 
(CH2), 41.3 (CH2), 31.9/31.2 (CH3), 30.7/30.5 (CH3), 20.6/18.4 (Ir-
CH2), 9.7/9.7 (Cp*). 11B{1H} NMR (96 MHz, C6D6 ? ?ɷ-1.4, -4.0, -
7.8, -11.3, -15.3. HRMS (ESI+): m/z [C21H39B10N2Ir]+ 620.3766, 
Calcd for [M]+ 620.3733. Anal. Calcd. for C21H39B10N2Ir: C, 40.69; 
H, 6.34; N, 4.52. Found: C, 40.80; H, 6.47; N, 4.30. Crystals 
suitable for X-ray diffraction analysis were grown by the slow 
evaporation of a concentrated solution of 4a in MeCN. 
Ir complex 2b 
To a Schlenk flask was added 1b (50 mg, 0.15 mmol), Ag2O (17 
mg, 0.075 mmol), [Ir(Cp*)Cl2]2 (60 mg, 0.073 mmol) and 
anhydrous CH2Cl2 (5 mL), along with some 4 Å molecular sieves. 
The reaction was heated at 40°C for 16 hours, filtered through 
celite and flushed with CH2Cl2 (3 × 5 mL). The solvent was 
removed from the filtrate in vacuo and the residue was 
recrystallised from acetone (5 mL) / pentane (30 mL), filtered 
and dried in vacuo to give 2b as a yellow solid. Yield: 86 mg, 0.13 
mmol (89 %). 1H NMR (300 MHz, CDCl3 ? ?ɷ ? ? ? ? ?Ě ?:с ?.0 Hz, 1H, 
NCH), 6.90 (d, J = 3.0 Hz, 1H, NCH), 4.94 (m, 1H, CH2), 4.45 (br. 
s, 1H, carboranyl CH), 3.97/3.95 (s, 3H, CH3), 3.71 (m, 1H, CH2), 
3.21 (m, 1H, CH2), 2.59 (m, 1H, CH2), 1.64/1.61 (s, 15H, Cp*). 
13C{1H} NMR (75 MHz, CDCl3 ? ?ɷ ? ? ? ? ? ?ECN), 124.3 (NCH), 121.3 
(NCH), 89.2 (quaternary Cp*), 71.9 (carboranyl quaternary C), 
60.9 (carboranyl CH), 49.7 (CH2), 39.1 (CH2), 38.8 (CH3), 9.5/9.3 
(Cp*). 11B{1H} NMR  ? ? ? D,ǌ ? ů ? ? ? ɷ-2.2, -5.0, -9.6, -13.0. 
HRMS (ESI+): m/z [C18H35B10N2IrCl]+ 615.3121, Calcd for [M-Cl]+ 
615.3106. Anal. Calcd for C18H35B10N2IrCl2: C, 33.22; H, 5.42; N, 
4.31. Found: C, 33.12; H, 5.34; N, 4.37. Crystals suitable for X-
ray diffraction analysis were grown by the slow diffusion of 
hexane into a concentrated solution of 2b in CH2Cl2. 
Rh complex 5b 
To a Schlenk flask was added 1b (50 mg, 0.15 mmol), Ag2O (17 
mg, 0.075 mmol), [Rh(Cp*)Cl2]2 (46 mg, 0.074 mmol) and 
anhydrous CH2Cl2 (5 mL), along with some 4 Å molecular sieves. 
The reaction was heated at 40°C for 16 hours, filtered through 
celite and flushed with CH2Cl2 (3 × 5 mL). The solvent was 
removed from the filtrate in vacuo and the residue was 
recrystallised from acetone (5 mL) / pentane (30 mL), filtered 
and dried in vacuo to give 5b as a yellow solid. Yield: 79 mg, 0.14 
mmol (95 %). 1H NMR (300 MHz, CDCl3 ? ?ɷ 7.04 (d, J = 3.0 Hz, 1H, 
NCH), 6.99 (d, J = 3.0 Hz, 1H, NCH), 5.02 (m, 1H, CH2), 4.62 (br. 
s, 1H, carboranyl CH), 4.00 (s, 3H, CH3), 3.76 (m, 1H, CH2), 3.20 
(m, 1H, CH2), 2.50 (m, 1H, CH2), 1.60 (s, 15H, Cp*). 13C{1H} NMR 
(75 MHz, CDCl3 ? ?ɷ171.9 (d, 1JRh-C = 52.5 Hz, NCN), 125.3 (NCH), 
122.2 (NCH), 96.6 (d, 1JRh-C = 7.5 Hz, quaternary Cp*), 71.9 
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(carboranyl quaternary C), 61.0 (carboranyl CH), 50.0 (CH2), 39.3 
(CH2), 38.8 (CH3), 9.6 (Cp*). 11B{1H} NMR (96 MHz, CDCl3 ? ?ɷ-2.2, 
-5.1, -9.7, -12.8. HRMS (ESI+): m/z 526.2550 [C18H35B10N2RhCl]+, 
Calcd for [M-Cl]+ 526.2525. Anal. Calcd for C18H35B10Cl2N2Rh: C, 
38.51; H, 6.28; N, 4.99. Found: C, 38.63; H, 6.32; N, 5.13. 
Ru complex 6b 
To a Schlenk flask was added 2b (50 mg, 0.15 mmol), Ag2O (17 
mg, 0.075 mmol), [Ru(p-cymene)Cl2]2 (46 mg, 0.075 mmol) and 
anhydrous CH2Cl2 (5 mL), along with some 4 Å molecular sieves. 
The reaction was heated at 40°C for 3 hours, filtered through 
celite and flushed with CH2Cl2 (3 × 5 mL). The solvent was 
removed from the filtrate in vacuo and the residue subjected to 
column chromatography on silica using a gradient elution with 
CH2Cl2 / MeOH (2%). Recrystallisation from MeCN gave 6b as a 
microcrystalline orange solid. Yield: 58 mg, 0.10 mmol (67 %). 
1H NMR (500 MHz, CD2Cl2): Major ɷ 7.08 (d, J = 2.0 Hz, 1H, NCH), 
7.03 (d, J = 2.0 Hz, 1H, NCH), 5.40 (d, J = 5.0 Hz, 2H, p-cymene 
Ar-H), 5.06 (d, J = 5.0 Hz, 2H, p-cymene Ar-H), 4.93 (br. s, 1H, 
CH2), 4.54 (br. s, 1H, carboranyl CH), 3.94 (s, 3H, CH3), 3.82 (br. 
s, 1H, CH2), 2.93 (br. s, 1H, CH2), 2.90 (septet, J = 10 Hz, 1H, 
isopropyl-CH), 2.64 (br. s, 1H, CH2), 1.93 (s, 3H, CH3), 1.26 (d, J = 
10 Hz, 6H, CH3). 13C{1H} NMR (126 MHz, CD2Cl2 ? ?ɷ175.6 (NCN), 
125.3 (NCH), 122.0 (NCH), 110.4 (p-cymene quaternary C), 99.4 
(p-cymene quaternary C), 86.4 (p-cymene CH), 82.4 (p-cymene 
CH), 72.6 (carboranyl quaternary C), 61.5 (carboranyl CH), 50.5 
(CH2), 39.9 (CH3), 39.0 (CH2), 31.2 (p-cymene isopropyl-CH), 23.0 
(p-cymene CH3), 21.9 (p-cymene CH3), 18.8 (p-cymene CH3). 
11B{1H} NMR (161 MHz, CDCl3): ɷ -2.4, -5.4, -9.8, -12.9. HRMS 
(ESI+): m/z [C18H34B10N2RuCl]+ 523.2460, Calcd for [M-Cl]+ 
523.2455. Anal. Calcd for C18H34B10N2RuCl2: C, 38.71; H, 6.14; N, 
5.02. Found: C, 38.63; H, 6.02; N, 5.12. Crystals suitable for X-
ray diffraction analysis were grown by the slow evaporation of 
a concentrated solution of 6b in MeCN. 
Ir complex 7b/8b mixture 
To a Schlenk flask was added 2b (100 mg, 0.15 mmol), Ag2O (52 
mg, 0.22 mmol) and anhydrous MeCN (5 mL) along with some 
4Å molecular sieves. The reaction was heated at 70°C for 16 
hours, filtered through a 2 cm silica plug and flushed with MeCN 
(2 × 10 mL). The solvent was reduced to 5 mL and the desired 
product was precipitated with Et2O (30 mL), filtered and the 
solvent removed in vacuo to give a mixture of 7b and 8b. Yield: 
52 mg, 0.08 mmol (53 %). The NMR spectra contain several sets 
of overlapping resonances (see Supporting Information) hence 
are not interpreted here. HRMS (ESI+): m/z [C18H34B10N2Ir]+ 
579.3350, Calcd for [M-Cl]+ 579.3340. Anal. Calcd for 
C18H34B10N2IrCl: C, 35.20; H, 5.58; N, 4.56. Found: C, 35.34; H, 
5.57; N, 4.63. 
Ir complex 7b 
To a Schlenk flask was added 1b (50 mg, 0.15 mmol) and 
anhydrous THF (5 mL). The solution was cooled to -78 °C and a 
1.6 M solution of nBuLi in hexane (13 ? ʅ> ?  ? ? ? ? ŵŵŽů ? ǁĂƐ
added dropwise. This was stirred at -78 °C for 30 minutes, then 
the temperature was then raised to 0 °C and stirred for a further 
1 hour. A solution of [IrCp*Cl2]2 in THF (3 mL) was added at 0°C 
and the reaction was stirred at room temperature for 12 hours. 
The solvent was removed in vacuo, CH2Cl2 (5 mL) added and 
filtered through a 2 cm silica plug which was flushed with CH2Cl2 
(2 × 10 mL). The solvent volume was reduced to 5 mL and the 
product precipitated with pentane (30 mL), filtered and dried in 
vacuo to give 7b as a yellow solid. Yield: 68 mg, 0.11 mmol (73 
%). 1H NMR (300 MHz, CD2Cl2 ? ?ɷ6.97 (m, 1H, NCH), 6.90 (s, 1H, 
NCH), 4.54 (m, 1H, CH2), 3.98/3.94 (s, 3H, CH3), 3.72 (m, 1H, 
CH2), 2.82 (m, 1H, CH2), 2.66 (m, 1H, CH2), 1.53/1.48 (Cp*). 
13C{1H} NMR (75 MHz, CD2Cl2): ɷ carbenic C not observed, 
126.0/125.9 (NCH), 121.2 (NCH), 93.8/93.5 (quaternary Cp*), 
46.2 (CH2), 42.3, 41.0, 39.2 (CH3), 9.6/9.3 (Cp*). HRMS (ESI+): 
m/z [C22H29B10N2Ir]+ 549.1650, Calcd for [M-X]+ 549.1635. 
Crystals suitable for X-ray diffraction analysis were grown by the 
slow evaporation of a concentrated solution of 7b in MeCN. 
Ir complex 2c 
2c was prepared as described for 2b, starting from 1c (50 mg, 
0.14 mmol), Ag2O (16 mg, 0.07 mmol), [Ir(Cp*)Cl2]2 (56 mg, 0.07 
mmol) and anhydrous CH2Cl2 (5 mL). After purification the 
product was obtained as a yellow solid. Yield: 80 mg, 0.12 mmol 
(86 %). 1H NMR (300 MHz, CDCl3 ? ?ɷ6.99 (d, J = 2.1 Hz, NCH), 
6.92 (d, J = 2.1 Hz, NCH), 5.04 (m, 1H, CH2), 3.99/3.97 (s, 3H, 
CH3), 3.84 (td, J = 12.0 Hz, 3 Hz, 1H, CH2), 3.41 (m, 1H, CH2), 2.48 
(m, 1H, CH2), 2.15 (s, 3H, CH3), 1.67/1.63 (Cp*). 13C{1H} NMR (75 
MHz, CDCl3 ? ?ɷ158.6 (NCN), 121.3 (NCH), 89.4/89.1 (quaternary 
Cp*), 74.9 (carboranyl quaternary C) (only one carboranyl 
quaternary C observed), 49.9 (CH2), 38.9 (CH3), 36.6 (CH2), 23.9 
(carboranyl CH3), 9.5/9.3 (Cp*). 11B{1H} NMR (96 MHz, CDCl3 ? ?ɷ
-3.7, -6.1, -10.0. HRMS (ESI+): m/z [C19H37B10N2IrCl]+ 629.3283, 
Calcd for [M-Cl]+ 629.3263. 
Ir complex 8c 
This complex was prepared as described for 7b/8b, starting 
from 2c (60 mg, 0.09 mmol), Ag2O (16 mg, 0.07 mmol) and 
anhydrous MeCN (5 mL). After purification 8c was obtained as 
a yellow solid. Yield, 25 mg, 0.04 mmol (44 %). 1H NMR (500 
MHz, CD3CN): ɷ ? ? ? ? ?Ě ?:с ? ? ?,ǌ ? ?, ?EH), 7.19 (d, J = 2.0 Hz, 
1H, NCH), 7.14 (d, J = 2.0 Hz, 1H, NCH), 7.11 (d, J = 2.0 Hz, 1H, 
NCH), 5.01 (td, J = 12.5 Hz, 6 Hz, 1H, CH2), 4.25 (m, 1H, CH2), 
4.02-3.95 (m, 1H, CH2), 3.73/3.71/3.61 (s, 3H, CH3), 3.17 (m, 1H, 
CH2), 2.72 (m, 1H, CH2), 2.30 (m, 1H, CH2), 2.17 (s, 1H, CH3), 
1.72/1.68/1.63 (Cp*). 13C{1H} NMR (126 MHz, CD3E ? ?ɷ ? ? ? ? ?
(NCH), 122.8 (NCH), 95.5/89.6 (quaternary Cp*), 50.5 (CH2), 
37.9, (CH2), 36.9 (CH3), 23.9 (CH3), 9.3, 9.2, 9.0, 8.8. 11B{1H} NMR 
(161 MHz, CD3E ? ?ɷ-4.2, -6.3, -8.5, -9.8, -10.6. HRMS (ESI+): 
m/z [C19H36B10N2Ir]+ 593.3513, Calcd for [M-Cl]+ 593.3497. Anal. 
Calcd for C19H36B10ClN2Ir: C, 36.32; H, 5.78; N, 4.46. Found: C, 
36.45; H, 5.77; N; 4.60. 
Ir complex 2d 
To a Schlenk flask was added 1d (50 mg, 0.19 mmol), Ag2O (22 
mg, 0.095 mmol), [Ir(Cp*)Cl2]2 (76 mg, 0.095 mmol) and 
anhydrous CH2Cl2 (5 mL) along with some 4Å molecular sieves. 
The reaction was heated at 40°C for 16 hours and filtered over 
celite, which was flushed with CH2Cl2 (3 × 5 mL). The solvent was 
removed from the filtrate in vacuo and the residue was 
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recrystallised from acetone (5 mL) with pentane (30 mL), 
filtered and dried in vacuo to give 2d as a yellow solid. Yield: 97 
mg, 0.17 mmol (89 %). 1H NMR (300 MHz, CDCl3 ? ?ɷ7.47-7.20 
(m, 5H, benzyl), 6.95-6.89 (m, 2H, NCH), 5.08 (dt, J = 12.0, 6.0 
Hz, 1H, CH2), 4.00/3.98 (s, 3H, CH3) 3.89 (dt, J = 12.0, 6.0 Hz, 1H, 
CH2), 3.50 (dt, J = 12.0, 6.0 Hz, 1H, CH2) 2.99 (dt, J = 12.0, 6.0 Hz, 
1H, CH2), 1.62/1.59 (s, 15H, Cp*). 13C{1H} NMR (75 MHz, CDCl3): 
ɷ 157.0 (NCN) 138.7 (benzyl), 129.4 (benzyl), 128.7 (benzyl), 
126.7 (benzyl), 123.5 (NCH), 121.5 (NCH), 88.8 (quaternary 
Cp*), 52.2 (CH2), 38.7 (CH3), 38.4 (CH2), 9.5/9.3 (Cp*). HRMS 
(ESI+): m/z [C22H29N2IrCl]+ 549.1650, Calcd for [M-Cl]+ 549.1635. 
Anal. Calcd for C22H29N2IrCl2: C, 45.20; H, 5.00; N, 4.79. Found: 
C, 45.06; H, 4.93; N, 4.85. 
Catalytic transfer hydrogenation general procedure 
Catalyst (0.01 or 0.005 mmol) and 1,3,5-trimethoxybenzene 
(55.5 mg, 0.33 mmol) were added to an ampoule and degassed. 
In a Glovebox, tBuOK (14 mg, 0.1 mmol) and acetophenone (117 
ʅ> ? ?ŵŵŽů ?were added to the ampoule. Under an atmosphere 
of N2, anhydrous iPrOH (2.30 mL, 30 mmol) was added and the 
reaction was heated at 82 °C for 1 hour. The reaction mixture 
was quenched by cooling in an ice bath and an aliquot (0.1 mL) 
was added to an NMR tube with CDCl3 (0.4 mL). Conversion was 
calculated using 1H NMR spectroscopy by comparing the 
integration of the methyl resonance of 1-phenylethanol with 
the internal standard, and values are an average of two 
separate runs. 
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